Small Molecules
10 December 2017
AstraZeneca’s CALQUENCE® (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial9 December 2017
Amphivena Presents Preclinical Data at ASH That Points to a Potentially New Treatment for MDS Patients8 December 2017
MediciNova Announces Positive Top-Line Results from the Clinical Trial of MN-166 (ibudilast) in ALS8 December 2017
Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer7 December 2017
Sage Therapeutics Reports Positive Top-line Results from Phase 2 Placebo-Controlled Trial of SAGE-217 in Major Depressive Disorder7 December 2017
H3 Biomedicine Presents Preclinical Data on Novel ERα Antagonist at San Antonio Breast Cancer Symposium6 December 2017
Arch Biopartners Announces Completion of GMP Manufacturing of AB569 and Start Date of Phase I Trial6 December 2017
Genoscience Pharma receives FDA approval for Phase Ib/IIa study of GNS561 in liver cancer5 December 2017
IMBRUVICA® (ibrutinib) Plus Rituximab Phase 3 iNNOVATE Trial in Rare Waldenström’s Macroglobulinemia Met Primary Endpoint5 December 2017
Realm Therapeutics Announces First Patient Dosed in Phase 2 Study of PR022 for the Treatment of Atopic Dermatitis4 December 2017
Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects4 December 2017
Updated larotrectinib pediatric clinical trial data demonstrate continued durability of response in TRK fusion cancers4 December 2017
Saniona AB: Saniona Selects Preclinical Candidate in GABAA a2/a3 Program for Neuropathic Pain and Chronic ItchingNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports